Adaptive Biotechnologies Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ADPT | PSNL | BLLN | RVTY | NEO | BDSX | |
|---|---|---|---|---|---|---|
| Market cap | 4.26B | 1.69B | 5.37B | 17.79B | 2.22B | 226.74M |
| P/E (TTM) | — | — | 180.8 | 70.9 | — | — |
| Forward P/E | -148.2 | -16.3 | 76.7 | 26.9 | 54.5 | -97.7 |
| Price/book | 18.8 | 6.2 | 9.9 | 2.5 | 2.8 | 24.8 |
| Dividend yield | — | — | — | 0.18% | — | — |
| 1-year change | +46.67% | +105.61% | +1.39% | +76.60% | +61.36% | +144.77% |
| Today | +3.53% | +0.25% | +3.11% | −2.48% | +1.90% | +2.09% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 15 min.
Latest news
All ADPT news ›Adaptive Biotechnologies raises 2026 MRD revenue guide to $276M-$286M as it targets $1,700-$1,800 ASP
Adaptive Biotechnologies Q3 2026 earnings: profitability, strong MRD growth, and raised guidance. Earnings Call Insights: Adaptive Biotechnologies (ADPT) Q3 2026 “Q3 was a breakthrough quarter for Adaptive. We achieved profitability at the…
Adaptive Biotechnologies Corporation (ADPT) Q3 2026 Earnings Call Transcript
Adaptive Biotechnologies Corporation (ADPT) Q3 2026 Earnings Call November 4, 2026 4:30 PM EST Karina Calzadilla - VP of Investor Relations and FP&AChad Robins - Co-Founder, CEO & ChairmanKyle Piskel - VP, CFO & Principal Accounting…
Adaptive Biotechnologies: Getting Paid Every Step Of The Way To A Myeloma Cure
Adaptive Biotechnologies gains from new myeloma MRD guidelines, strong clonoSEQ growth, and refinancing tailwinds. Read why ADPT stock is a buy. - Adaptive Biotechnologies benefits from new NCCN guidelines and IMS cure definitions,…
Adaptive Biotechnologies (NASDAQ:ADPT) COO Julie Rubinstein Sells 11,881 Shares of Stock
Julie Rubinstein also recently made the following trade(s): View Our Latest Report on ADPT Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is a biotechnology company focused on using the genetics of the adaptive immune system to…
More from 1 other outlet
Critical Comparison: Adaptive Biotechnologies (NASDAQ:ADPT) versus Quantum-Si (NASDAQ:QSI)
Posted by Danessa Lincoln on Oct 27th, 2026 Adaptive Biotechnologies (NASDAQ:ADPT – Get Free Report) and Quantum-Si (NASDAQ:QSI – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two…
Castle Biosciences CEO sells 14,496 shares
Castle Biosciences (CSTL) is a Nasdaq-listed diagnostics company focused on molecular tests for dermatologic and gastroenterological diseases and skin cancers. - [Form 4] CASTLE BIOSCIENCES INC Insider Trading Activity Castle Biosciences…
Castle Biosciences COO sells 4,153 shares
Castle Biosciences (CSTL) is a Nasdaq-listed diagnostics company focused on molecular tests for dermatologic and gastroenterological diseases and skin cancers. - [Form 4] CASTLE BIOSCIENCES INC Insider Trading Activity Castle Biosciences…
ImmunityBio director Cheryl Cohen sells 81,056 shares
Tesla Releases Third Quarter 2026 Financial Results QuantumScape Announces Plans for 100 MWh Solid-State Battery Production Line for AI Data Centers, Aerospace and Defense Alpha Modus Announces $7.25 Million Registered Direct Offering of…
Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells $304,272.41 in Stock
Adaptive Biotechnologies Corporation (NASDAQ:ADPT – Get Free Report) COO Julie Rubinstein sold 11,881 shares of the stock in a transaction that occurred on Thursday, October 15th. The shares were sold at an average price of $25.61, for a…
Alert incorrectly tagged to Adaptive Biotechnologies withdrawn
An alert from agentic accounting platform Adaptive announcing a fundraise was inadvertently tagged to publicly listed Adaptive Biotechnologies Corp, an unrelated company, and has been... Biotechnology & Medical Research Alert incorrectly…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net10
- marketscreener.com5
- defenseworld.net4
- seekingalpha.com3
- marketbeat.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 27 articles, not a forecast.